- Home
- BAX vs JEF Comparison
BAX vs JEF Comparison
Compare BAX & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BAX | JEF |
|---|---|---|
| Founded | 1931 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 10.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BAX | JEF |
|---|---|---|
| Price | $18.60 | $59.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $25.67 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 8.3M | 1.7M |
| Earning Date | 10-30-2025 | 01-07-2026 |
| Dividend Yield | 0.22% | ★ 2.71% |
| EPS Growth | N/A | ★ 25.06 |
| EPS | N/A | ★ 2.92 |
| Revenue | ★ $11,023,000,000.00 | $7,231,501,000.00 |
| Revenue This Year | $5.20 | $5.85 |
| Revenue Next Year | $2.02 | $9.97 |
| P/E Ratio | ★ N/A | $20.42 |
| Revenue Growth | 3.90 | ★ 15.68 |
| 52 Week Low | $17.40 | $39.28 |
| 52 Week High | $37.74 | $82.68 |
Technical Indicators
Market Signals| Indicator | BAX | JEF |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 60.60 |
| Support Level | $18.33 | $55.98 |
| Resistance Level | $19.17 | $58.25 |
| Average True Range (ATR) | 0.54 | 2.07 |
| MACD | 0.21 | 0.54 |
| Stochastic Oscillator | 63.23 | 89.10 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About JEF Jefferies Financial Group Inc.
Jefferies is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since merging, Jefferies became the bedrock of the business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.